MoneyWorks4Me

Glenmark Pharmaceuticals board to consider unaudited financial statements

18 Jan 2013 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on January 29, 2013, to consider and approve the company’s un-audited financial statements for the Third Quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..